(Q35592638)

9 August 2017

1 reference

title

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis (English)

1 reference

9 August 2017

0 references

1

Ghislain Opdenakker

0 references

author name string

Inge Nelissen

series ordinal

2

1 reference

9 August 2017

Jo Van Damme

series ordinal

3

1 reference

9 August 2017

publication date

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

2

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

747-756

1 reference

A full genome search in multiple sclerosis

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Genomewide scan of multiple sclerosis in Finnish multiplex families

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Multiple sclerosis: trial of a synthetic polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Transcriptional analysis of targets in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Analysis of a sequenced cDNA library from multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Microarray analysis of gene expression in multiple sclerosis and EAE identifies 5-lipoxygenase as a component of inflammatory lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Distinct gene expression of osteopontin in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gene expression studies using microarrays: principles, problems, and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gelatinase B: a tuner and amplifier of immune functions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Metalloproteinases and their tissue inhibitors in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

1 reference

7 January 2021

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Transmigration of PBMNCs from beta-IFN-1b-treated MS patients: a one-year longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Proteolytic balance in patients with multiple sclerosis during interferon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Human Monocyte-Derived Dendritic Cells Produce Bioactive Gelatinase B: Inhibition by IFN-β

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloproteinases degrade myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Cytokine-regulated proteases in autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Distinct recognition by two subsets of T cells of an MHC class II-peptide complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Tolerance controls encephalitogenicity of alphaB-crystallin in the Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Encephalitogenic and immunogenic potential of the stress protein alphaB-crystallin in Biozzi ABH (H-2A(g7)) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

A novel rationale for inhibition of gelatinase B in multiple sclerosis: MMP-9 destroys alpha B-crystallin and generates a promiscuous T cell epitope.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Inhibition of autoimmune encephalomyelitis by a tetracycline.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

A controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation. The signaling role of protein kinase C-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The MCP/eotaxin subfamily of CC chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Structural and functional analysis of the promoter region of the human MCP-3 gene: transactivation of expression by novel recognition sequences adjacent to the transcription initiation site.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Chemokine expression in GKO mice (lacking interferon-gamma) with experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Role of chemokines, neuronal projections, and the blood-brain barrier in the enhancement of cerebral EAE following focal brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Chemokine expression in murine experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

CCR5 and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

New developments in anti-HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Multiple paths towards repair in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

Metalloproteinases in biology and pathology of the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900587-8

7 January 2021

10.1016/S1474-4422(03)00587-8

Identifiers

DOI

1 reference

9 August 2017

1 reference